Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bradley M. Hover"'
Autor:
Sarah Charlop-Powers, Sean F. Brady, Jeanne Garbarino, Paula Y. Calle, Bradley M. Hover, Helen M. Forgione, Krista L. McGuire, Clara C. Pregitzer, Zachary Charlop-Powers, Jeffrey Maniko, Christophe Lemetre, Melinda A. Ternei
Publikováno v:
Proceedings of the National Academy of Sciences. 113:14811-14816
Numerous therapeutically relevant small molecules have been identified from the screening of natural products (NPs) produced by environmental bacteria. These discovery efforts have principally focused on culturing bacteria from natural environments r
Publikováno v:
Journal of Industrial Microbiology and Biotechnology. 43:129-141
Bacterial natural products have proven to be invaluable starting points in the development of many currently used therapeutic agents. Unfortunately, traditional culture-based methods for natural product discovery have been deemphasized by pharmaceuti
Publikováno v:
Biochemistry. 54:7229-7236
Molybdenum cofactor (Moco) is essential for all kingdoms of life, plays central roles in various biological processes, and must be biosynthesized de novo. During its biosynthesis, the characteristic pyranopterin ring is constructed by a complex rearr
Autor:
Steven Park, Seong-Hwan Kim, Zachary Charlop-Powers, Jeremy G. Owen, Micah Katz, David S. Perlin, Andreia B. Estrela, Sean F. Brady, Melinda A. Ternei, Bradley M. Hover, Henrik Molina, Jeffrey Maniko
Publikováno v:
Nature microbiology. 3(4)
Despite the wide availability of antibiotics, infectious diseases remain a leading cause of death worldwide 1 . In the absence of new therapies, mortality rates due to untreatable infections are predicted to rise more than tenfold by 2050. Natural pr
Publikováno v:
SLAS Discovery. 19:387-398
The identification of small molecules that positively modulate the mitochondrial respiratory function has broad applications in fundamental research, therapeutic target validation, and drug discovery. We present an approach in which primary screens f
The molybdenum cofactor (Moco) is essential for all kingdoms of life, plays central roles in various biological processes, and must be biosynthesized de novo. During Moco biosynthesis, the characteristic pyranopterin ring is constructed by a complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b42b9d2264addc4bdc02582324a9fab3
https://europepmc.org/articles/PMC4443348/
https://europepmc.org/articles/PMC4443348/
Autor:
Bradley M. Hover, Kenichi Yokoyama
The molybdenum cofactor (Moco) is an essential redox cofactor found in all kingdoms of life. Genetic mutations in the human Moco biosynthetic enzymes lead to a fatal metabolic disorder, Moco deficiency (MoCD). Greater than 50% of all human MoCD patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95a9f19e3244c76209d0188d0a87d5a
https://europepmc.org/articles/PMC4831585/
https://europepmc.org/articles/PMC4831585/
Publikováno v:
Journal of the American Chemical Society. 135(18)
The molybdenum cofactor (Moco) is a redox cofactor found in all kingdoms of life, and its biosynthesis is essential for survival of many organisms, including humans. The first step of Moco biosynthesis is a unique transformation of guanosine 5'-triph